Blake Bell was diagnosed with Parkinson’s at the age of 49. He recalls that his neurologist took three minutes to examine him and delivered the words that rocked his world: “I’m sorry to say, you have Parkinson’s.” “After the shock of the diagnosis, I went into denial,” Blake says. “I hid from the disease, trying very hard not to think … Read More
Parkinson Canada and Catalyst Healthcare announce partnership focused on promoting medication adherence for Canadians with Parkinson’s
Toronto, ON (April 20, 2021) — As a trusted partner and advisor for Canadians with Parkinson’s, Parkinson Canada has been focusing on the importance of proper medication management when speaking with people impacted by Parkinson’s and healthcare professionals. The primary message of its ACT on Time® campaign is that people with Parkinson’s disease need to get their medication on time, … Read More
COVID-19 and Parkinson’s
As the vaccine is rolling out in phases, several provinces have updated eligibility criteria for vaccine prioritization. While Parkinson’s may not broadly qualify for prioritization, we encourage members of our community to review the information on vaccine eligibility provided by their local public health unit/authority to determine if they qualify for prioritization based on their unique circumstances. Specific commentary on … Read More
Parkinson Canada advocates for more awareness and support during awareness month in light of COVID-19 pandemic
Parkinson Canada calls for better care for those affected by rising neurological disorder Toronto, ON (March 31, 2021) — Parkinson Canada, a non-profit that supports all aspects in helping combat the impacts of the disease, is calling for better awareness and support of those affected by the neurological disorder in light of Parkinson’s Awareness Month starting April 1. The month … Read More
Parkinson Canada calls for more support for Canadians living with chronic disease and caregivers
Diagnostic, screening and treatment delays have always had a significant impact on Canadians living with Parkinson’s and the impacts of COVID-19 are being felt by our community and beyond. Parkinson Canada is grateful for the support of HealthPartners and the attention they are bringing to these national poll results. We join them in calling for attention to the impact of … Read More
New research shows gut fungi are not associated with Parkinson’s
Since 2014, researchers such as Dr. Silke Appel-Cresswell have been studying the gut as a key area in potentially unravelling the mysteries of what causes Parkinson’s to develop. Although Parkinson’s disease kills brain cells that affect our ability to move and to reason, the trillions of micro-organisms living in our gastrointestinal tracts may be important contributors to the illness. Dr. … Read More
Newly established Parkinson Advisory Council (PAC) prioritizes raising the voice of people affected by Parkinson’s
Raising the voice of people affected by Parkinson’s has always been an important priority of Parkinson Canada and was one of the guiding principles behind Karen Lee’s CEO Listening Tour this summer, hosted just months after joining the organization. What became clear there is the priority for a greater inclusion of the Parkinson Voice – your voice – in the … Read More
CEO Dr. Karen Lee talks Parkinson Canada’s plans for 2021 on podcast
More than ever, we are here to listen to and support the Parkinson Community, no matter what. This is the idea behind our recently announced 2021-2023 strategic plan, one that Dr. Karen Lee and the rest of Parkinson Canada is eager to move forward with. Karen, President and CEO of Parkinson Canada, talks about what that looks like on the … Read More
Living Well with Parkinson’s, Together: No Matter What
Thanks to the support of donors, volunteers and everyone who is part of the Parkinson Community, Parkinson Canada has been able to be a support system for over 55 years. As part of a changing world, we are evolving to better serve individuals and families with the same purpose: A better life today for Canadians living with Parkinson’s; a world … Read More
BlueRock Therapeutics in Collaboration with Memorial Sloan Kettering Cancer Center Receives IND Clearance for DA01 in Parkinson’s Disease
BlueRock Therapeutics shared a news release on January 7, 2020 announcing the funding of a two-year trial using adult donor stem cells. Parkinson Canada’s view: This news is a “[s]ignificant development in North America as the US FDA approves it’s first trial to study the use of pluripotent stem cell-derived dopaminergic neurons in patients with Parkinson’s disease. The system uses … Read More